The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Tatiana Kutateladze to the position of Editor at Cancer Epigenetics (CE) journal series.
Dr. Kutateladze is a Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA). Her research interests include studying epigenetic mechanisms, posttranslational histone modifications, and the role of epigenetic misregulations in human diseases, cancer in particular. The Kutateladze’s laboratory has substantially contributed to deciphering the epigenetic language through characterizing structures and functions of chromatin-binding and chromatin-remodeling complexes. Her laboratory applies the latest breakthroughs in high field NMR spectroscopy and X-ray crystallography to unveil the atomic-resolution structures and mechanistic aspects of chromatin-interacting proteins involved in transcriptional regulation and DNA damage repair and implicated in cancer. Among her many achievements, Dr. Kutateladze is credited with elucidating the molecular mechanisms of the methyllysine and acyllysine recognition by a large number of epigenetic readers, including plant homeodomain (PHD), YEATS, Tudor, bromodomain, CW, and PZP.
The Cancer Epigenetics Society congratulates Dr. Tatiana Kutateladze for her nomination to the Editorial Board of Cancer Epigenetics journal series, and looks forward to working with her in publishing the best research unraveling the structural determinants of the cancer epigenetics code .